Felipe Fregni is an Associate Professor of Neurology and the director of the Neuromodulation Laboration at Spaulding Rehabilitation Hospital, Harvard Medical School - a state-of-the-art laboratory focused on the investigation of novel methods of neuromodulation for neuropsychiatric disorders. Dr. Fregni (MPH '07 and Lemann Fellow 2007-2008) has received numerous promising young researchers from Brazil in his lab. He has conducted clinical trials and also mechanistic studies investigating the effects of noninvasive neuromodulatory tools on the treatment of neuropsychiatric disorders. Some of these highly cited studies investigated the impact of neuromodulation on motor function, mood and cognition, as well as brain activity changes using neuroimaging (SPECT). While pushing the boundaries of neuromodulation, Dr. Fregni still has kept a focus on addressing the issues of chronic pain, being the first to publish a trial investigating the impact of transcranial direct current stimulation for chronic pain in spinal cord injury. The focus of his research has largely centered upon developing methods of neuromodulation as potential treatment tools as well as investigating their mechanisms and impact on brain plasticity. The ultimate goal is to develop novel methods of neuromodulation for the treatment of neuropsychiatric disorders.